Results 31 to 40 of about 6,142,918 (314)

The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant)

Cancer Cell International, 2021
Purpose An increasing number of studies have reported a significant association between long non-coding RNAs (lncRNAs) dysregulation and pancreatic cancers.
Elahe Seyed Hosseini, Ali Nikkhah, Amir Sotudeh, Marziyeh Alizadeh Zarei, Fatemeh Izadpanah, Hossein Nikzad, Hamed Haddad Kashani   +6 more
doaj   +1 more source

Progression‐free survival as a surrogate marker of overall survival [PDF]

Cancer, 2011
The use of progression‐free survival as a surrogate marker of efficacy in cancer treatment has been the subject of much discussion in recent years. However, it should not be considered a surrogate marker for overall survival.
openaire   +2 more sources

Progression-free survival analysis.

, 2019
Progression-free survival analysis.
Donglin Zhu (231422), Rongming Shen (7041791), Yong Yang (63842), Hongya Xie (529445), Guangda Yuan (7041788), Tengteng Wei (7041785)   +5 more
core   +1 more source

Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer

The Application of Clinical Genetics, 2022
Naglaa S Elabd,1 Shimaa E Soliman,2 Moamena S Elhamouly,1 Suzy F Gohar,3 Ayman Elgamal,4 Mahmoud Magdy Alabassy,5 Haitham A Soliman,5 Abdelnaser A Gadallah,6 Osama D Elbahr,7 Ghada Soliman,3 Amany A Saleh2 1Tropical Medicine Department, Faculty of ...
Elabd NS, Soliman SE, Elhamouly MS, Gohar SF, Elgamal A, Alabassy MM, Soliman HA, Gadallah AA, Elbahr OD, Soliman G, Saleh AA   +10 more
doaj  

Progression-free survival rate.

, 2019
Progression-free survival rate.
Sonia Tejada (4023731), Luis Ramos (550823), José Javier Aristu (6808193), Miguel Ángel Idoate (6808184), Paola Anna Jablonska (6808178), Ricardo Diez-Valle (198834), Marta Moreno-Jiménez (6808181), Maria Reyes Garcia de Eulate (6808187), Pablo Domínguez (4023716), Jaime Gállego Pérez-Larraya (842444), Leire Arbea (6686129), Javier Arbizu (6808190)   +11 more
core   +1 more source

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

Acta Oncologica
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. Patients and methods: We set out to determine progression-free survival (PFS) after front line, second line, and third line of
Aino Rajamaki, Marc Sorigue, Roosa E.I. Prusila, Milla E.L. Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Taina Turpeenniemi-Hujanen, Juan-Manuel Sancho, Kaisa Sunela, Outi Kuittinen   +10 more
doaj   +1 more source

Progression-free survival and survival estimates for TDM vs. NTDM.

, 2019
Progression-free survival (PFS, blue) and survival (orange) estimates. Estimates from TDM on solid lines; estimates from NTDM on dotted lines. Note: Progression-Free Survival: likelihood of staying in CP with either imatinib or second-generation TKI ...
Philip S. Bernard (8173509), Srinivas Tantravahi (8173512), Gwendolyn A. McMillin (8173506), Robert L. Schmidt (8173518), Kibum Kim (1420720), Brandon S. Walker (8173515)   +5 more
core   +1 more source

Progression-free survival between the Collatamp group and the control group.

, 2022
There was no significant difference in the estimated 2-year progression-free survival rate between the two groups (log-rank p-value = 0.092).
Jaeim Lee (11204526), Seong Taek Oh (10208648), Youn Young Park (10208645), Kil-yong Lee (6050867)   +3 more
core   +1 more source

Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective

Contemporary Oncology, 2016
We still do not know whether the presently used protocol of the first-line palliative treatment of disseminated colorectal cancer (FOLFOX/FOLFIRI protocol) allows maximization of therapeutic response and minimization of side effects.
Wojciech Rogowski, Violetta Sulżyc-Bielicka   +1 more
doaj   +1 more source

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer

Frontiers in Nutrition, 2023
BackgroundThe purpose of this study was to investigate the prognostic significance of sarcopenia diagnosed based on anthropometric equations for progression-free survival (PFS) and overall survival (OS) in patients with colorectal cancer (CRC).MethodsA ...
Hailun Xie, Hailun Xie, Lishuang Wei, Shunhui Gao, Shunhui Gao, Mingxiang Liu, Mingxiang Liu, Yanren Liang, Yanren Liang, Guanghui Yuan, Guanghui Yuan, Qiwen Wang, Qiwen Wang, Yansong Xu, Shuangyi Tang, Jialiang Gan, Jialiang Gan   +16 more
doaj   +1 more source